News & Events

Dec 01, 2021

NDRI Elects Paul M. Lieberman, Ph.D., to Board of Directors

-Philadelphia-based National Disease Research Interchange (NDRI) announces the election of Paul M. Lieberman, Ph.D., to its Board. Lieberman is the Hilary Koprowski, M.D., Endowed Professor, leader of the Gene Expression and Regulation Program, and director of the Center for Chemical Biology & Translational Medicine at The Wistar Institute, a biomedical research leader in cancer, immunology, infectious disease, and vaccine development. Elected on November 12 to a three-year term, Lieberman will bring his experience and insight to the nation’s leading source of human organs, cells, and tissues for research. Click here to read the full press release.

NDRI is a Not-For-Profit (501c3) Corporation.